Clinical Trials
3 trialsNot yet recruiting × Metastatic Castration-resistant Prostate Cancer (mCRPC) × Genitourinary × Clear all
NCT07310355 2025-12-30
68Ga-PSMA-0057 and 177Lu-PSMA-0057 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
Chengdu StarRay Therapeutics Co., Ltd
Phase 1/2 Not yet recruiting
NCT07244393 2025-11-24
Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer
Cellbion Co., Ltd.
Phase 1 Not yet recruiting
NCT07104617 2025-08-05
Study of TY-302 Capsules Combined With Abiraterone in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）
TYK Medicines, Inc
Phase 1/2 Not yet recruiting